HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS
LATEST UPDATES » Vol 25, No. 05, May 2020 – Surviving COVID-19: Personal Experience of Dr. J Richard Smith       » Open Source AI-Powered Tool by Tencent for COVID-19 Preliminary Self Evaluation       » COVID-19 and its Impact on a Global and Societal Scale       » Optimal Egg Consumption to Lower Risk of Cardiovascular Disease       » Cohort Analysis of Remdesivir as Antiviral Treatment for COVID-19       » Easing Strain on Healthcare Systems with COVID-19 Patient Management Platform      
Vol 24, No. 05, May 2020For e-subscribers (PDF)
BIOBOARD
Study Finds Underweight Patients with Diabetes have Increased Risk of Tuberculosis
New study nested in the long-running Singapore Chinese Health Study found that those who suffer from diabetes and are underweight have a much higher risk of active tuberculosis (TB).

It has been established that diabetes is a risk factor for active TB disease. Epidemiologic studies have also shown that individuals with low body mass index (BMI), especially those who fall within the lean or underweight range have an increased risk of active TB compared to those with higher BMI.

In western populations, increased BMI is a risk factor for diabetes with most patients with diabetes having a high BMI. By contrast, in Asian populations, a large proportion of patients with diabetes are lean or even underweight. This proves the public health importance to study the joint effect of diabetes and BMI in modulating the risk of TB in Asian populations.

The research team was led by Professor Koh Woon Puay from the Duke-NUS Medical School and the National University of Singapore’s Saw Swee Hock School of Public Health. Using data from the Singapore Chinese Health study, a population-based study, they were able to examine the combined association of diabetes and BMI with risk of active TB disease.

Professor Koh, the Principal Investigator of the Singapore Chinese Health Study, explained, “The key finding in this study is that diabetes and low BMI are independent risk factors for active TB disease. Hence, patients with diabetes and who are also lean or underweight have a substantially increased risk from the effects of both factors.”

Dr Cynthia Chee, a co-author of the study, commented, “Singapore’s TB incidence rate of 35 to 40 per 100,000 population is 5–10 times that of the US, Australia and the UK. Diabetes is a major problem in Singapore, affecting one in nine persons aged 18 to 69. In order to bring down our TB rate, it is important for all physicians to have a heightened awareness of the link between diabetes and TB, so as to facilitate the early diagnosis of active TB in this important risk group.”

“The National Tuberculosis Programme – also known as the Singapore Tuberculosis Elimination Programme, or STEP – welcomes the publication of this landmark study and is proud to have played a part,” said Adjunct Associate Professor Jeffery Cutter, Acting Director, National Tuberculosis Programme, National Centre for Infectious Diseases.

Through the results of this study, Professor Anthony Harries, a renowned researcher in TB from the International Union Against Tuberculosis and Lung Disease called for physicians in diabetes clinics to practice targeted screening focussing on underweight individuals. Also, for future research to study the value of targeted TB preventive therapy among underweight diabetic patients.

Click here for the complete issue.

NEWS CRUNCH  
news Medtec China to return in September with integrated manufacturing resources for the entire high-end medical industry chain
news Joining Forces to Elevate Asia's Healthcare Industry
news 4th Global Feed Summit draws Feed Producers, Technology Providers, Raw Materials Suppliers to Bangkok for Key Discussions
news 2nd China Pharma Digital Innovation Summit to be held in Shanghai
SPOTLIGHT  

MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Contribute to APBN
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Deborah Seah
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   biotech_ad@wspc.com
Copyright© 2020 World Scientific Publishing Co Pte Ltd  •  Privacy Policy